
|Articles|March 24, 2020
Guiding Teams through Organizational Change
Author(s)Merz Therapeutics
Trending on PharmExec
1
Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report
2
Trump Administration Preparing New Round of Medicaid Drug-Pricing Deals: Report
3
FDA Approves Daraxonrasib as First-in-Class Targeted Therapy for Metastatic Pancreatic Cancer
4
The Retailization of Medicare Advantage: What Costco’s Entry Means for Pharma
5




